Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report

Acta Derm Venereol. 2021 Nov 10;101(11):adv00589. doi: 10.2340/00015555-3888.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Chilblains*
  • Humans
  • Interferon Type I*
  • RNA, Messenger / genetics
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • Interferon Type I
  • RNA, Messenger